Found: 11
Select item for more details and to access through your institution.
BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 531, p. 1, doi. 10.1126/scitranslmed.aax2625
- By:
- Publication type:
- Article
The Identification of Large Rearrangements Involving Intron 2 of the CDH1 Gene in BRCA1/2 Negative and Breast Cancer Susceptibility.
- Published in:
- Genes, 2022, v. 13, n. 12, p. 2213, doi. 10.3390/genes13122213
- By:
- Publication type:
- Article
Risk of Serous Endometrial Carcinoma in Women With Pathogenic BRCA1/2 Variant After Risk-Reducing Salpingo-Oophorectomy.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2018, v. 110, n. 2, p. 1, doi. 10.1093/jnci/djx159
- By:
- Publication type:
- Article
HORMAD1 overexpression predicts response to anthracycline–cyclophosphamide and survival in triple‐negative breast cancers.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 10, p. 2017, doi. 10.1002/1878-0261.13412
- By:
- Publication type:
- Article
Array comparative genomic hybridization identifies high level of PI3K/Akt/mTOR pathway alterations in anal cancer recurrences.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 7, p. 3213, doi. 10.1002/cam4.1533
- By:
- Publication type:
- Article
The high protein expression of FOXO3, but not that of FOXO1, is associated with markers of good prognosis.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-63895-8
- By:
- Publication type:
- Article
Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609).
- Published in:
- Journal of Hematology & Oncology, 2018, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13045-018-0670-9
- By:
- Publication type:
- Article
5′ Region Large Genomic Rearrangements in the BRCA1 Gene in French Families: Identification of a Tandem Triplication and Nine Distinct Deletions with Five Recurrent Breakpoints.
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3171, doi. 10.3390/cancers13133171
- By:
- Publication type:
- Article
Value of the loss of heterozygosity to BRCA1 variant classification.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-021-00361-2
- By:
- Publication type:
- Article
Interaction between IGF2‐PI3K axis and cancer‐associated‐fibroblasts promotes anal squamous carcinogenesis.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 7, p. 1852, doi. 10.1002/ijc.32178
- By:
- Publication type:
- Article
Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection.
- Published in:
- 2016
- By:
- Publication type:
- journal article